MCL

In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss diagnostic testing options for patients with suspected neuroinvasive Lyme disease or Lyme neuroborreliosis.

In July 2018, Mayo Medical Laboratories announced five new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

In June 2018, Mayo Medical Laboratories announced three new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

While online retailers experiment with drones as a way to swiftly deliver consumer purchases, laboratory medicine physicians and scientists have a lifesaving goal: using drones to rapidly deliver laboratory specimens.

High-sensitivity troponin T is a new assay recently approved by the U.S. Food and Drug Administration. This assay is most often used to evaluate patients with possible acute ischemic heart disease, but it also has a variety of uses in the more chronic setting.

In April 2018, Mayo Medical Laboratories announced two new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

For people with encephalitis, rapid treatment of their acute brain inflammation is critical for avoiding devastating physical and cognitive deficits. But appropriate treatment requires identifying the culprit causing the symptoms.

Mike Baisch, Principal Systems Engineer at Mayo Clinic, discusses staffing to workload in phlebotomy areas with a focus on "on-site operational needs," which is defined as "staff effort that does not deal directly with patients or their samples, or with the indirect tasks needed to support those patient-care efforts."

In March 2018, Mayo Medical Laboratories announced fifteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

Justin Kreuter, M.D., Clinical Pathologist and Medical Director of the Mayo Clinic Blood Donor Center in Rochester, Minnesota, highlights inter-professional collaboration through a recap of #Transfuse18.

A breakthrough in pathology, achieved more than a century ago (allegedly on a frozen window ledge in Rochester, Minnesota) has evolved into an innovative aspect of care at Mayo Clinic. Mayo is one of the only medical centers in the United States to routinely use a tissue-freezing process that provides analysis of tissue samples while the patient is still in the operating room.

Mike Baisch, Principal Systems Engineer at Mayo Clinic, discusses staffing to workload in phlebotomy areas with a focus on indirect effort, which includes tasks performed that don’t involve the patient or a patient’s sample.

In February 2018, Mayo Medical Laboratories announced two new tests along with numerous reference value changes, obsolete tests, and algorithm changes.